Health
Drug to treat OCD could reduce hospitalisation risk in Covid patients, study in Lancet says – ThePrint
The study says antidepressant fluvoxamine could reduce the production of inflammatory molecules called cytokines that can be…
New Delhi: Fluvoxamine, an antidepressant used for the treatment of major depressive disorders and obsessive-compulsive disorder (OCD), can reduce the need for hospitalisation among high-risk Covid-19 patients, according to the results of a new clinical…
Continue Reading
-
Noosa News14 hours ago‘Sunny, benign’ school holiday weather after morning showers in parts of Queensland
-
Noosa News24 hours agoWoman loses arm in lion attack at Darling Downs Zoo in Queensland
-
Noosa News23 hours agoMissing man, Maroochydore – Queensland Police News
-
General12 hours agoAustralian picture books aim to give neurodivergent kids a better sense of self